Human herpesviruses are known to induce a broad spectrum of diseases, ranging from common cold sores to cancer, and infections with some types of these viruses, known as human oncogenic herpesviruses (HOHVs), can cause cancer. Challenges with viral latency, recurrent infections, and drug resistance have generated the need for finding new drugs with the ability to overcome these barriers. Berberine (BBR), a naturally occurring alkaloid, is known for its multiple biological activities, including antiviral and anticancer effects. This paper comprehensively compiles all studies that have featured anti-HOHV properties of BBR along with promising preventive effects against the associated cancers. The mechanisms and pathways induced by BBR via targeting the herpesvirus life cycle and the pathogenesis of the linked malignancies are reviewed. Approaches to enhance the therapeutic efficacy of BBR and its use in clinical practice as an anti-herpesvirus drug are also discussed.

• Klíčová slova
• Epstein–Barr virus, Kaposi’s sarcoma-associated herpesvirus, berberine, cancer, herpes simplex virus, human cytomegalovirus, inflammation, oncogenic herpesviruses,
• MeSH
• antivirové látky terapeutické užití   MeSH
• berberin terapeutické užití   MeSH
• Herpesviridae klasifikace   účinky léků   patogenita   MeSH
• herpetické infekce komplikace   farmakoterapie   MeSH
• karcinogeneze účinky léků   MeSH
• klinické zkoušky jako téma MeSH
• latence viru účinky léků   MeSH
• lidé MeSH
• myši MeSH
• nádory farmakoterapie   virologie   MeSH
• replikace viru účinky léků   MeSH
• zánět farmakoterapie   virologie   MeSH
• zvířata MeSH
• Check Tag
• lidé MeSH
• myši MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• přehledy MeSH
• Názvy látek
• antivirové látky MeSH
• berberin MeSH